Unicycive Therapeutics (UNCY)

• Market cap: $130M
• 1 day: 0%
• 5 days: -13.82%
• 1 month: 1.07%
• 3 months: -38.12%
• 6 months: -20.6%
• Year to date: -18.28%
• 1 year: 7.24%
• 5 years: -82.83%
• 10 years: -91.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Employees: 22